Abstract
The aim of this study was to evaluate whether modifiable cardiovascular disease (CVD) risk factors, e.g. atherogenic blood lipids, hypertension and lifestyle-related factors such as smoking, diet and physical inactivity, differ among patients with ankylosing spondylitis (AS) in comparison to the general population. Eighty-eight patients diagnosed with AS were identified by analysis of the databases of a previous community intervention programme, the Västerbotten intervention programme. The patients were compared with 351 controls matched for age, sex and study period. These databases include the results of blood samples analysed for cholesterol, triglycerides and plasma glucose, as well as data on hypertension, height, weight, smoking and dietary habits and physical activity. No significant differences were found between patients and controls regarding hypertension, body mass index, physical activity, diet or smoking. Levels of serum triglycerides (p < 0.01) and cholesterol (p < 0.01) were significantly lower in the patient group. Among the patients, the level of triglycerides correlated inversely with the intake of total fat (r s = −0.25, p < 0.05), monounsaturated fats (r s = −0.29, p < 0.05) and positively correlated to the intake of carbohydrates (r s = 0.26, p < 0.05). These associations were not apparent among the controls. In the cohort of AS patients studied, no differences were found regarding the modifiable risk factors for CVD compared with the general population. Hence, the increased presence of CVD in patients with AS may be caused by other factors such as differences in metabolism and medication such as NSAID or the chronic low-grade inflammation present in the disease.
Similar content being viewed by others
References
Kinsella TD, MacDonald FR, Johnson LG (1966) Ankylosing spondylitis: a late re-evaluation of 92 cases. Can Med Assoc J 95:1
Bulkley BH, Roberts WC (1973) Ankylosing spondylitis and aortic regurgitation: description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 48:1014–1027
Roldan CA, Chavez J, Wiest PW, Qualls CR, Crawford MH (1998) Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 32:1397–1404
Dik VK, Peters MJ, Dijkmans PA et al (2010) The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 39:38–41
Han C, Robinson DWJ, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172
Hollan I, Saatvedt K, Almdahl SM et al (2008) Spondyloarthritis: a strong predictor of early coronary artery bypass grafting. Scand J Rheumatol 37:18–22
Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70:1921–1925
van Dam RM, Li T, Spiegelman D, Franco OH, Hu FB (2008) Combined impact of lifestyle factors on mortality: prospective cohort study in US women. BMJ 337:a1440
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–52
Hahn BH, Grossman J, Chen W, McMahon M (2007) The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28:69–75
Weinehall L, Hellsten G, Boman K, Hallmans G (2001) Prevention of cardiovascular disease in Sweden: the Norsjo community intervention programme—motives, methods and intervention components. Scand J Public Health Suppl 56:S13–20
Norberg M, Wall S, Boman K, Weinehall L (2010) The vasterbotten intervention programme: background, design and implications. Glob Health Action 3:4643
Weinehall L, Hallgren CG, Westman G, Janlert U, Wall S (1998) Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care 16:171–6
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–8
Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R (2002) Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr 5:487–96
Johansson I, Van Guelpen B, Hultdin J, Johansson M, Hallmans G, Stattin P (2010) Validity of food frequency questionnaire estimated intakes of folate and other B vitamins in a region without folic acid fortification. Eur J Clin Nutr 64:905–913
Bergström L, Hagman U, Eriksson H, Bruce Å (1991) The food composition data base system (KOST systemet)—its use for nutrient values [Swedish]. Vår Föda 43:439–47
Johansson G, Westerterp KR (2008) Assessment of the physical activity level with two questions: validation with doubly labeled water. Int J Obes 32:1031–3
Schofield WN (1985) Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 39(Suppl 1):5–41
Johansson G, Åkesson Å, Nermell B, Berglund M, Vahter M (1998) Validation with biological markers for food intake of a dietary assessment method used by Swedish women with three different dietary preferences. Public Health Nutr 1:199–206
Johansson G, Wikman A, Ahrén AM, Hallmans G, Johansson I (2001) Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutr 4:919–927
Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr Suppl 65:1220S–8S
Kang JH, Chen YH, Lin HC (2010) Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study. Ann Rheum Dis 69(6):1165–8
Bremander A, Petersson IF, Bergman S, Englund M (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 63:550–556
Mathieu S, Gossec L, Dougados M, Soubrier M (2011) Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 63:557–563
Sundström B, Wållberg-Jonsson S, Johansson G (2010) Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis. Clin Rheumatol 30:71–6
Sundström B, Johansson G, Kokkonen H, Cederholm T, Wållberg-Jonsson S (2012) Plasma phospholipid fatty acid content is related to disease activity in ankylosing spondylitis. J Rheumatol 39:327–33
van Halm VP, van Denderen JC, Peters MJ, Twisk JW, van der Paardt M, van der Horst-Bruinsma IE et al (2006) Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65:1473–7
Divecha H, Sattar N, Rumley A, Cherry L, Lowe GD, Sturrock R (2005) Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 109:171–6
McCarey D, Sturrock RD (2009) Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol Suppl 27:S124–6
Hu FB, Willett WC (2002) Optimal diets for prevention of coronary heart disease. JAMA 288:2569–78
Rall LC, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford) 43:1219–23
Staal-van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF (1995) Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13:2600–5
Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442–52
Acknowledgments
We gratefully acknowledge Sonja Odeblom for skilful administrative help. Åsa Ågren and Anna-Sara Molin at Northern Sweden Medical Research Bank are thanked for help in gaining access to the data. This work was supported by grants from the northern county councils Visare Norr, the Borgerskapet fund in Umeå, the Department of Research Norrbotten county council and the Swedish Rheumatism Association.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table 1
(DOCX 15 kb)
Rights and permissions
About this article
Cite this article
Sundström, B., Johansson, G., Johansson, I. et al. Modifiable cardiovascular risk factors in patients with ankylosing spondylitis. Clin Rheumatol 33, 111–117 (2014). https://doi.org/10.1007/s10067-013-2410-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2410-4